ImmuPharma plc (LON:IMM – Get Free Report)’s share price rose 28.6% during mid-day trading on Wednesday . ImmuPharma Stock PerformanceThe business’s 50 day simple moving average is GBX 5.49 and its 200-day simple moving average is GBX 3.64. As a group, sell-side analysts expect that ImmuPharma plc will post -339.0000022 EPS for the current year. ImmuPharma Company ProfileImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. Featured ArticlesReceive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.